Www.medicalppt.blogspot.com for more lecture notes Antianginal Agents Dr.Shadi-Sarahroodi Pharm.D & PhD Qom University of Medical sciences Iran PUBLISHED.

Slides:



Advertisements
Similar presentations
MEDPHARM DRUGS FOR ISCHEMIC HEART DISEASE FEBRUARY 10,2110.
Advertisements

CASE 21 Michelle Legaspi. 65 y/o male retired teacher sought consult because of occasional chest heaviness non-radiating occuring during a moderate physical.
Coronary vasodilators Antianginal drugs  Angina pectoris: is a clinical syndrome characterized by paroxysm of pain in the anterior chest caused by insufficient.
ANGINA PECTORIS. Angina pectoris (chest pain) is the result of myocardial ischemia caused by an imbalance between myocardial blood supply and oxygen demand.
Cardiovascular pharmacology Chapter 32 Antianginal drugs China Medical University.
Drugs to treat angina. I. Introduction Branching off the aorta are the coronary arteries.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 51 Drugs for Angina Pectoris.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and.
Calcium antagonists (Summary) Dr Ivan Lambev
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 45 Calcium Channel Blockers.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 24 Antianginal Drugs.
Spasm/obstruction of coronary arteriesMyocardial ischemiaReduced O2 supply to myocardium Chest pain---Angina pectoris Angina pectoris Chest pain due to.
Angina Pectoris “Chest pain” or angina pectoris is a symptom of ischemic heart disease caused by an imbalance between oxygen requirement of the heart and.
Beta-Adrenergic Blockers  Types of adrenoceptors Alpha-1  Vasoconstriction  Increased peripheral resistance  Increased blood pressure Alpha-2  Inhibition.
Calcium Antagonists Tatyana Voyno-Yasenetskaya
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
Cardio pharmacology Angina. angina Causes Atheroma Others: Aortic stenosis, aberrant coronary circulation, severe anaemia, arteritis Prevention Decrease.
1 ANGINA ANGINA MYOCARDIAL OXY. DEMAND >. OXY. SUPPLY. OXY. SUPPLY < SYMPTOMS – chest pain mostly relieved by taking rest, dyspnea, sweating, nausea..
21 Drugs Used to Treat Cardiovascular Conditions.
MAIN EXIT NEXT Definition Types of Angina Management of Angina Antianginal drugs BY: DR. MARWA SHAALAN.
Drugs in the Therapy of Angina Dr. Thomas Abraham PHAR417: Fall 2004.
Antianginal Drugs Lilley Reading and Workbook – Chap 23.
Drug Therapy Heart Failure by Pat Woodbery, MSN, ARNP.
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
Antianginal Drugs Learning outcomes Recognize variables contributing to a balanced myocardial supply versus demand Expand on the drugs used to alleviate.
Drug Treatment of Ischemic Heart Disease Fixed "Stable" Angina Variant Angina Unstable Angina Myocardial Infarction.
BIMM118 Angina pectoris Medical term for chest pain or discomfort due to coronary heart disease. Typical angina pectoris (=“tight heart” is uncomfortable.
They bind to the channel from the inner side of the membrane. They bind to channels in depolarized membranes. Binding  ↓ frequency of opening of the channels.
Antianginal drugs Angina pectoris is the severe chest pain that occurs when coronary blood flow is inadequate to supply the oxygen required by the heart.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and.
Ischemic heart diseases Ischemia : it is inadequate supply of O2 to an organ or tissue (result from inadequate blood flow) insufficient to meet the organ’s.
Therapeutics for Coronary Vascular Disease Nitrates.
Drugs used in angina pectoris
Angina pectoris Sudden, severe, pressing chest pain and radiating to the neck, jaw, back, and arms. The episodes are transient, stay between 15 sec to.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 23 Antianginal Drugs.
Antianginal drugs Antidysrrhytmic drugs
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm & neck. Due to imbalance between myocardium oxygen requirement.
Anti-anginal Drugs Angina pectoris is a characteristic sudden severe pressing chest pain or heaviness radiating to the neck, jaw, back and arms. It is.
ANTIANGINAL AGENTS. Atherosclerotic disease of the coronary arteries, also known as coronary artery disease or ischemic heart disease, is the most common.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Calcium antagonists (Summary) Dr Ivan Lambev
Adrenergic Antagonists
MCQs framed from High yield areas of Anti-anginal Pharmacology
Antianginal (Anti-ischaemic) Drugs
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Drugs for Angina Pectoris.
Drugs for Angina Pectoris
PHARMACOLOGY OF ANTI-ANGINAL DRUGS (ID#580) Dr. Mariam Yousif Pharmacology & Toxicology Dept. November 17 th, 2014.
Anti- anginal drugs.
21 Drugs Used to Treat Cardiovascular Conditions.
Calcium Channel Blocking Drugs.
Drug Therapy of Angina Pectoris
Antianginal Drugs Learning outcomes
Anti-Anginal Drugs.
Antianginal Drugs Learning outcomes
Formative Test.
New Paradigm of Anti Anginal Therapy dr.Yerizal Karani SpPD,SpJP(K)
Anti Anginal Agents Pharmacology Week 10.
Antianginal Drugs Ischemic Heart Disease Angina pectoris
ANTI-ANGINAL DRUGS February 2017.
Anti-Anginal Drugs.
NITRATES 20/01/2011.
Treatment of Angina Pectoris [æn‘dʒaɪnə] [’pektəris] 心绞痛治疗
ORGANIC NITRATES February 2017.
Antianginal Drugs.
Antianginal Drugs Ass. Prof. Naza M. Ali Lec 3-4 G2 21 April 2019
Antianginal Drugs Learning outcomes
Antianginal Drugs Learning outcomes
Anti Anginal Agents Pharmacology Week 10.
Presentation transcript:

for more lecture notes Antianginal Agents Dr.Shadi-Sarahroodi Pharm.D & PhD Qom University of Medical sciences Iran PUBLISHED BY

for more lecture notes Angina Pectoris (Chest Pain) When the supply of oxygen and nutrients in the blood is insufficient to meet the demands of the heart, the heart muscle aches. When the supply of oxygen and nutrients in the blood is insufficient to meet the demands of the heart, the heart muscle aches.

for more lecture notes Types of Angina Atherosclerotic angina (also called classic or effort angina) Atherosclerotic angina (also called classic or effort angina) Vasospastic angina (also called Prinzmetal’s or variant angina) Vasospastic angina (also called Prinzmetal’s or variant angina) Unstable angina (also called preinfarction or crescendo angina) Unstable angina (also called preinfarction or crescendo angina)

for more lecture notes Antianginal Agents: Therapeutic Objectives Increase blood flow to ischemic heart muscle Increase blood flow to ischemic heart muscleand/or Decrease myocardial oxygen demand Decrease myocardial oxygen demand

for more lecture notes Antianginal Agents Nitrates Nitrates Beta blockers Beta blockers Calcium channel blockers Calcium channel blockers

for more lecture notes intracellular conversion to nitrite ions, and then to nitric oxide intracellular conversion to nitrite ions, and then to nitric oxide activates guanylate cyclase and increases the cells' cyclic guanosine monophosphate (cGMP). activates guanylate cyclase and increases the cells' cyclic guanosine monophosphate (cGMP). Elevated cGMP ultimately leads to dephosphorylation of the myosin light chain, resulting in vascular smooth muscle relaxation Elevated cGMP ultimately leads to dephosphorylation of the myosin light chain, resulting in vascular smooth muscle relaxation

for more lecture notes Organic Nitrates Ferid Murad

for more lecture notes Antianginal Agents: Nitrates Available forms: SublingualOintments BuccalTransdermal patches Chewable tabletsInhalable sprays CapsulesIntravenous solutions

for more lecture notes BENEFITS OF NITRATES Reduce myocardial oxygen demand by dilating veins and increase venous pooling of blood Reduce myocardial oxygen demand by dilating veins and increase venous pooling of blood Increase systemic arteriolar vasodilation (intravenous forms only) Increase systemic arteriolar vasodilation (intravenous forms only) Directly dilate undiseased coronary arteries, helping restore blood flow deep within myocardial tissues Directly dilate undiseased coronary arteries, helping restore blood flow deep within myocardial tissues Decrease ventricular wall tension due to increased venous pooling Decrease ventricular wall tension due to increased venous pooling Improve exercise tolerance Improve exercise tolerance

for more lecture notes Antianginal Agents: Nitrates Nitroglycerin Prototypical nitrate Prototypical nitrate Large first-pass effect with PO forms Large first-pass effect with PO forms Used for symptomatic treatment of ischemic heart conditions (angina) Used for symptomatic treatment of ischemic heart conditions (angina) IV form used for BP control in perioperative hypertension, treatment of CHF, ischemic pain, and pulmonary edema associated with acute MI IV form used for BP control in perioperative hypertension, treatment of CHF, ischemic pain, and pulmonary edema associated with acute MI

for more lecture notes Antianginal Agents: Nitrates isosorbide dinitrate (Isordil, Sorbitrate, Dilatrate SR) isosorbide dinitrate (Isordil, Sorbitrate, Dilatrate SR) isosorbide mononitrate (Imdur, Monoket, ISMO) isosorbide mononitrate (Imdur, Monoket, ISMO) Used for: Acute relief of angina Acute relief of angina Prophylaxis in situations that may provoke angina Prophylaxis in situations that may provoke angina Long-term prophylaxis of angina Long-term prophylaxis of angina

for more lecture notes

Antianginal Agents: Nitrates Side Effects Headache Headache –Usually diminish in intensity and frequency with continued use Tachycardia, postural hypotension Tachycardia, postural hypotension Tolerance may develop Tolerance may develop facial flushing, and tachycardia facial flushing, and tachycardia

for more lecture notes Tolerance blood vessels become desensitized to vasodilation blood vessels become desensitized to vasodilation daily “nitrate-free interval” daily “nitrate-free interval” typically 10 to 12 hours, usually at night, because demand on the heart is decreased at that time typically 10 to 12 hours, usually at night, because demand on the heart is decreased at that time variant angina worsens early in the morning, perhaps due to circadian catecholamine surges variant angina worsens early in the morning, perhaps due to circadian catecholamine surges

for more lecture notes Antianginal Agents: Beta Blockers

for more lecture notes Antianginal Agents: Beta Blockers Mechanism of Action Decrease the HR, resulting in decreased myocardial oxygen demand and increased oxygen delivery to the heart Decrease the HR, resulting in decreased myocardial oxygen demand and increased oxygen delivery to the heart Decrease myocardial contractility, helping to conserve energy or decrease demand Decrease myocardial contractility, helping to conserve energy or decrease demand

for more lecture notes Propranolol is the prototype: not cardioselective Propranolol is the prototype: not cardioselective metoprolol or atenolol, are preferred metoprolol or atenolol, are preferred

for more lecture notes All β-blockers are nonselective at high doses and can inhibit β 2 receptors. All β-blockers are nonselective at high doses and can inhibit β 2 receptors. Important in asthmatics. Important in asthmatics.

for more lecture notes contraindication Asthma Asthma Diabetes Diabetes severe bradycardia severe bradycardia peripheral vascular disease peripheral vascular disease chronic obstructive pulmonary disease. chronic obstructive pulmonary disease.

for more lecture notes Do not discontinue β-blocker therapy abruptly. Do not discontinue β-blocker therapy abruptly. The dose should be gradually tapered off over 5 to 10 days to avoid rebound angina or hypertension.] The dose should be gradually tapered off over 5 to 10 days to avoid rebound angina or hypertension.]

for more lecture notes Antianginal Agents: Calcium Channel Blockers

for more lecture notes Mechanism of Action Calcium influx is increased in ischemia because of the membrane depolarization that hypoxia produces Calcium influx is increased in ischemia because of the membrane depolarization that hypoxia produces In turn, this promotes the activity of several adenosine triphosphate– consuming enzymes, thereby depleting energy stores and worsening the ischemia In turn, this promotes the activity of several adenosine triphosphate– consuming enzymes, thereby depleting energy stores and worsening the ischemia

for more lecture notes Antianginal Agents: Calcium Channel Blockers Cause peripheral arterial vasodilation Cause peripheral arterial vasodilation Reduce myocardial contractility (negative inotropic action) Reduce myocardial contractility (negative inotropic action) Result: decreased myocardial oxygen demand Result: decreased myocardial oxygen demand

for more lecture notes Nifedipine a dihydropyridine derivative a dihydropyridine derivative arteriolar vasodilator arteriolar vasodilator Oral Oral Usually: extended-release tablets. Usually: extended-release tablets. Hepatic metabolism Hepatic metabolism Eliminate in both urine and the feces Eliminate in both urine and the feces

for more lecture notes Side Effects Flushing Flushing Headache Headache Hypotension Hypotension peripheral edema as peripheral edema as all calcium-channel blockers are with constipation is a problem all calcium-channel blockers are with constipation is a problem

for more lecture notes Verapamil Slows AV conduction Slows AV conduction decreases heart rate, contractility, blood pressure, and oxygen demand decreases heart rate, contractility, blood pressure, and oxygen demand contraindicated in patients with preexisting depressed cardiac function or AV conduction abnormalities contraindicated in patients with preexisting depressed cardiac function or AV conduction abnormalities

for more lecture notes Diltiazem slow AV conduction slow AV conduction decrease the rate of firing of the sinus node pacemaker decrease the rate of firing of the sinus node pacemaker metabolized by the liver metabolized by the liver

for more lecture notes PUBLISHED BY PUBLISHED BY